We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,562

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYLN icon
5026
Hyliion Holdings
HYLN
$725M
$2.06M ﹤0.01%
1,232,836
+661,571
+116% +$1.11M
GH icon
5027
PUT
Guardant Health
GH
$21.1B
$2.06M ﹤0.01%
57,500
-36,000
-39% -$1.03M
SDIV icon
5028
Global X SuperDividend ETF
SDIV
$1.22B
$2.06M ﹤0.01%
+91,077
New +$2.02M
ICPT
5029
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.06M ﹤0.01%
185,900
+74,100
+66% +$1.03M
IHI icon
5030
PUT
iShares US Medical Devices ETF
IHI
$3.47B
$2.06M ﹤0.01%
36,400
+18,800
+107% +$1.04M
NEWR
5031
PUT
DELISTED
New Relic, Inc.
NEWR
$2.05M ﹤0.01%
31,400
+6,400
+26% +$462K
TV icon
5032
Televisa
TV
$1.53B
$2.05M ﹤0.01%
400,152
-1,248,183
-76% -$6.27M
VIRT icon
5033
PUT
Virtu Financial
VIRT
$5.3B
$2.05M ﹤0.01%
120,100
-172,700
-59% -$3.17M
VEU icon
5034
CALL
Vanguard FTSE All-World ex-US ETF
VEU
$70.6B
$2.05M ﹤0.01%
37,700
+14,100
+60% +$764K
PDFS icon
5035
PDF Solutions
PDFS
$2.15B
$2.05M ﹤0.01%
45,475
-132,525
-74% -$5.41M
WRLD icon
5036
CALL
World Acceptance Corp
WRLD
$908M
$2.05M ﹤0.01%
15,300
-15,700
-51% -$1.69M
BRBR icon
5037
PUT
BellRing Brands
BRBR
$1.25B
$2.05M ﹤0.01%
56,000
+900
+2% +$32.3K
MRTX
5038
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.05M ﹤0.01%
56,700
-13,900
-20% -$573K
BSY icon
5039
Bentley Systems
BSY
$10.9B
$2.05M ﹤0.01%
37,756
-142,212
-79% -$6.64M
MGK icon
5040
CALL
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.9B
$2.05M ﹤0.01%
43,500
-37,500
-46% -$1.62M
EGO icon
5041
Eldorado Gold
EGO
$10.4B
$2.05M ﹤0.01%
202,611
+97,758
+93% +$1.04M
SLP icon
5042
Simulations Plus
SLP
$371M
$2.05M ﹤0.01%
47,225
-54,461
-54% -$2.38M
BB icon
5043
CALL
BlackBerry
BB
$5.22B
$2.05M ﹤0.01%
370,000
-27,900
-7% -$135K
ERIE icon
5044
Erie Indemnity
ERIE
$13.4B
$2.05M ﹤0.01%
9,738
-6,036
-38% -$1.35M
ESTA icon
5045
CALL
Establishment Labs
ESTA
$2.37B
$2.04M ﹤0.01%
29,800
-9,700
-25% -$670K
VRDN icon
5046
Viridian Therapeutics
VRDN
$2.5B
$2.04M ﹤0.01%
85,849
+3,794
+5% +$97.3K
WU icon
5047
PUT
Western Union
WU
$2.32B
$2.04M ﹤0.01%
174,000
-74,400
-30% -$857K
GPOR icon
5048
PUT
Gulfport Energy Corp
GPOR
$3.01B
$2.04M ﹤0.01%
19,400
+4,300
+28% +$399K
WW
5049
CALL
DELISTED
WW International
WW
$2.04M ﹤0.01%
302,900
+78,600
+35% +$557K
FMC icon
5050
PUT
FMC
FMC
$1.27B
$2.03M ﹤0.01%
19,500
-19,700
-50% -$2.21M

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.